AtriCure Sells 5,000 Shares: Insider Move or Pattern Worth Watching?
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Spreadsheets are powerful tools for investment planning. Discover how to utilize them to track and manage your investments efficiently.
20,347 articlesA senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Target’s dividend king status remains intact for now, but a cash flow squeeze and higher capex raise questions for in...
The Vanguard Health Care ETF has underperformed the broader market by roughly 57 points over five years, yet patient ...
As AI accelerates efficiency, middle managers face restructuring across industries. Investors are weighing earnings i...
Peabody Energy shares fell nearly 6% after a quarterly report that missed profitability targets. This article breaks ...
Investors are watching Bullish (BLSH) as Q1 2026 results set the tone for the year. This guide breaks down the earnin...
Nebius Group flags a fragile link between borrowing costs and AI investment. The remarks underscore how rate moves fr...
When a high-profile investor shifts a crypto position, the market takes notice. mark cuban says sold most of his Bitc...
Looking for a long-term growth plan? This article highlights three growth stocks to hold next for the next two decade...
Raising pay is not a cure for financial anxiety. New data show savings rates slipping even as wages rise, underscorin...
When shares slip, income-minded investors can find rare opportunities. This guide spotlights three magnificent divide...
In May, Redwire surged as investors weighed earnings, AI data-center potential, and a SpaceX IPO rumor mill. This gui...